Great News! With the addition of Nevada and Florida, half the country now has oral anticancer treatment parity legislation to make access easier for patients. However, this means that half the country is still not protected from possibly facing thousands of dollars in co-pays for oral treatments.
The IMF led the coalition in Nevada that lead to passage of SB 266 earlier this month. Thank you to the Joyce Family and everyone in Nevada who reached out to their state legislators. “As a result, Nevada patients living with multiple myeloma will soon have affordable access to the most effective treatment for their cancer without having to worry about breaking the bank,” said Zina Cary of the International Myeloma Foundation. Read More
After two years of outreach, Florida Governor Scott signed the Cancer Treatment Fairness Act into law on June 6. Working together with other cancer organizations, IMF patients and caregivers played a key role by collecting over 400 postcards in support of the Cancer Treatment Fairness Act that were delivered to both state representatives and the Governor asking for their support. Thank you to everyone who asked people in their lives to support this critical legislation.
On the other coast in California, AB 219 will have a hearing in the Senate Health Committee on Wednesday June 26. The bill passed the Assembly in April. Email your State Senator today and ask for their support of AB 219. Take Action!
In Ohio, sponsor testimony was heard last week in the Senate Insurance Committee in support of SB 99. This is the first of four hearings the bill will have in the committee before reaching the full Senate for a vote. Express your support today.
Advocates in Wisconsin are stepping up the pressure on state legislators to introduce oral anticancer treatment legislation this summer. Team members are setting up meetings with their legislators and expressing their support of the legislation. If you are interested in joining the efforts of the Wisconsin Action Team, click here to email Tom and Mary.
In addition to state work, we have been working at the federal level on HR 1801, The Cancer Drug Coverage Parity Act, which has made great strides since introduction. There are now 43 bipartisan co-sponsors, bringing us closer to where we ended last year. The Myeloma ACTION Team is working with advocates in their areas to set up in-district meetings with key committee members this summer to continue building support for this critical measure. Email Aimee if you would like to set up a meeting with your Representative on HR 1801.
1,570 total views, 1 views today